Navigation Links
Publication Addresses Misconceptions About Emergency Contraception
Date:3/27/2008

MONTVALE, N.J., March 27 /PRNewswire/ -- The approval of an emergency contraceptive with over-the-counter access for individuals aged 18 years and older provides another option for preventing unintended pregnancy. However, many patients are uninformed or misinformed about how emergency contraception works and when they may need it. Clinicians should to be able to address these questions and proactively counsel patients about their risk of pregnancy.

To address this issue, OBG Management and The Journal of Family Practice have collaborated to publish "Emergency contraception: When and how to use it," distributed as a supplement to the February 2008 issues.

This publication provides clinicians with valuable information about emergency contraception. A handout sheet for patients was included to reinforce clinical counseling efforts. The publication highlights effective strategies for collaboration between clinicians and pharmacists to promote access to emergency contraception.

Supplement co-author Joseph S. Sanfilippo, MD, MBA, remarked on the relevance of this material, in light of the recent report from the CDC that shows an increased incidence of teen pregnancy: "Emergency contraception will avert the problems intrinsic to conception in this age group. Studies show that teen education about Plan B is not associated with any increase in incidence of teen sexual activity."

OBG Management, a peer-reviewed journal distributed to 40,000 ob/gyns, and The Journal of Family Practice, a peer-reviewed journal distributed to 96,000 primary care physicians, have developed this supplement under a grant from Duramed Pharmaceuticals, Inc.

Physicians can access this supplement on http://www.obgmanagement.com and on http://www.jfponline.com. Nurse practitioners and physician assistants can find this publication at http://www.apctoday.com, an online resource for advanced practice clinicians.

OBG Management and The Journal of Family Practice are published by Dowden Health Media, a Division of Lebhar-Friedman, Inc. Dowden Health Media is a full-service healthcare communications company that specializes in high-quality communication with physicians, advanced practice clinicians, and consumers. Its highly respected, peer-reviewed journals reach more than 300,000 physicians and clinicians in surgery, psychiatry, family practice, internal medicine & obstetrics/gynecology.


'/>"/>
SOURCE The Journal of Family Practice; OBG Management
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
2. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
3. Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents
4. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
5. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
6. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
7. Research by Case Western Reserve University, VA earns cover of prestigious science publication
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
10. Industry Executives Finding Value in Shift of Scientific Publications
11. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):